title: [Chemoembolization of primary hepatic carcinoma with portal vein tumor thrombus].
abstract: Forty cases of primary hepatic carcinoma(PHC) with portal vein tumor thrombus(PTT) underwent chemoembolization twice or more. The total effective rate was 67.5%. The survival rates of half, one, and three years were 75.0%, 12.5%, and 2.5% respectively after the treatment. The mean survival time was 9 months. The effective rate of the cases with the branch PTT was higher than other cases(P < 0.05). The influence caused by the average treatment interval had no significant difference(P > 0.05). It is suggested that (1) in case of controlling the applications, TAI + TAE is an effective therapy of PHC with PTT; (2) no matter where PTT is, an active management must be adopted; (3) the average treatment interval shall be decided according to conditions of the patients.
authors.affiliation: Department of Radiology, Xiangya Hospital, Hunan Medical University, Changsha 410008.
authors.forename: J
authors.initials: J
authors.lastname: Cao
authors.forename: H
authors.initials: H
authors.lastname: Li
authors.forename: X
authors.initials: X
authors.lastname: Wang
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016461:Chemoembolization, Therapeutic; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D009360:Neoplastic Cells, Circulating / Q000473:pathology; D011169:Portal Vein / Q000473:pathology; D020246:Venous Thrombosis / Q000628:therapy*
chemical_list: D016685:Mitomycin; D004317:Doxorubicin